Castle Biosciences, Inc. (CSTL)

21.50 -3.25 (-13.13%) USD  |  NASDAQ  |  May 07, 11:02
More

Castle Biosciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for CSTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Delcath Systems, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
CytoSorbents Corp. Upgrade
Odyssey Health, Inc. --
Harmony Biosciences Holdings, Inc. Upgrade